Use of protein PLST as a marker for colorectal cancer
AssigneeRoche Diagnostics Operations, Inc.
InventorsMichael Tacke, Peter Berndt, Marie-Luise Hagmann, Johann Karl, Hanno Langen, Stefan Palme, Markus Roessler, Wolfgang Rollinger, Werner Zolg
Life of this patent
Estimating the term…
Abstract
The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein PLST (T-plastin) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PLST in said sample. Measurement of PLST can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Claims9
A method for the diagnosis of colorectal cancer comprising the steps of:
- (a) providing a liquid sample obtained from an individual,
- (b) contacting the sample with a specific binding agent for T-plastin (PLST) whereby a complex is formed between the binding agent and PLST,
- (c) measuring an amount of complex formed, and
- (d) correlating the amount of complex formed to the diagnosis of colorectal cancer.
An immunological kit comprising at least one specific binding agent for PLST and auxiliary reagents for measurement of PLST.
A method for determining the presence or amount of T-plastin (PLST) in a biological sample comprising the steps of:
- (a) contacting the sample with a specific binding agent for PLST whereby a complex is formed between the binding agent and PLST,
- (b) measuring the amount of complex formed in step (a), and
- (c) correlating the amount measured in step (b) to the presence or amount of PLST in the sample.
Dependencies are inferred from the claim text.